OPTIMAL TIME TO SURGERY AFTER NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA: IS THERE AN IDEAL WINDOW?

被引：0
|
作者：
Crocker, Andrew B.
Winer, Leah
O'Halloran, Eileen A.
Barrak, Dany
Devarajan, Karthik
Reddy, Sanjay S.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1173
引用
收藏
页码：S1510 / S1510
页数：1
相关论文
共 50 条
  • [41] Racial Ethnic Disparities in Access to Neoadjuvant Therapy for Pancreatic Adenocarcinoma
    Kangas-Dick, A. W.
    Greenbaum, A. A.
    Gazivoda, V. P.
    Hilden, P. D.
    Gall, V. A.
    Sesti, J.
    Paul, S.
    August, D. A.
    Kennedy, T. J.
    Grandhi, M. S.
    Alexander, H. R.
    Maggi, J. C.
    Langan, R. C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S91 - S91
  • [42] Perioperative complication rates following neoadjuvant therapy in pancreatic adenocarcinoma
    Deig, Christopher R.
    Beneville, Blake
    Liu, Amy
    Kanwar, Aasheesh
    Grossblatt-Wait, Alison
    Sheppard, Brett C.
    Gilbert, Erin W.
    Lopez, Charles D.
    Billingsley, Kevin G.
    Nabavizadeh, Nima
    Thomas, Charles R.
    Grossberg, Aaron
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [43] Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma
    Jiang, Wei
    Haque, Waqar
    Verma, Vivek
    Butler, E. Brian
    Teh, Bin S.
    [J]. ACTA ONCOLOGICA, 2019, : 1259 - 1266
  • [44] PROPENSITY SCORE MATCHED ANALYSIS OF NEOADJUVANT THERAPY VERSUS UPFRONT SURGERY FOR RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
    Yoon, Minsung
    Lee, Hee Seung
    Bang, Seungmin
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S867 - S867
  • [45] Neoadjuvant therapy in pancreatic ductal adenocarcinoma: A competing risk analysis
    Pacilio, Carlo Alberto
    Grassi, Elisa
    Gardini, Andrea
    Fappiano, Francesca
    Passardi, Alessandro
    Frassineti, Giovanni Luca
    Tamberi, Stefano
    Ercolani, Giorgio
    [J]. SURGICAL PRACTICE, 2022, 26 (03) : 155 - 164
  • [46] THE IMPACT OF NEOADJUVANT THERAPY ON VASCULAR RESECTION IN PANCREATIC DUCTAL ADENOCARCINOMA
    Crocker, Andrew B.
    Barrak, Dany
    Hopkins, Steven E.
    Egleston, Brian
    Reddy, Sanjay S.
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1556 - S1556
  • [47] PATIENT STATED PREFERENCES FOR NEOADJUVANT THERAPY IN PANCREATIC DUCTAL ADENOCARCINOMA
    Cloyd, Jordan
    Tsung, Allan
    Ejaz, Aslam
    Pawlik, Timothy M.
    Sarna, Angela
    Santry, Heena P.
    Wills, Celia
    Crossnohere, Norah
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S903 - S904
  • [48] Disparities in the Use of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma
    Cloyd, Jordan M.
    Shen, Chengli
    Santry, Heena
    Bridges, John
    Dillhoff, Mary
    Ejaz, Aslam
    Pawlik, Timothy M.
    Tsung, Allan
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (05): : 556 - +
  • [49] Neoadjuvant Therapy Is Associated With Improved Survival in Resectable Pancreatic Adenocarcinoma
    Artinyan, Avo
    Anaya, Daniel A.
    McKenzie, Shaun
    Ellenhorn, Joshua D. I.
    Kim, Joseph
    [J]. CANCER, 2011, 117 (10) : 2044 - 2049
  • [50] Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
    Awad, Seifeldin
    Alkashash, Ahmad M.
    Amin, Magi
    Baker, Samantha J.
    Rose, J. Bart
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
12345